AMAM

Ambrx Biopharma, Inc. Common Stock

Delisted

AMAM was delisted on the 6th of March, 2024.

16 hedge funds and large institutions have $18M invested in Ambrx Biopharma, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
4
Closed
2
Calls
Puts
Net Calls
Net Calls Change